ACTRN12617001346369招募中1 期
The pharmacokinetics and pharmacodynamics of a single dose of febuxostat (80 mg) in healthy subjects.
St Vincent's Hospital, Sydney0 个研究点目标入组 10 人开始时间: 2017年9月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 70 Years(—)
- 性别
- All
入选标准
- •Healthy subjects
排除标准
- •Subject with a history of any chronic disease.
研究者
相似试验
已完成
不适用
The effect of body weight on rivaroxaban disposition in healthy human volunteersRivaroxaban disposition in healthy human volunteers (obese vs non-obese population)ISRCTN12520248Qatar University36
招募中
1 期
Evaluation of intravenous or subcutaneous administration of ublituximab in patients with multiple sclerosisCTIS2023-509555-13-00Tg Therapeutics Inc.60
进行中(未招募)
不适用
Pharmacokinetics, pharmacodynamics and safety of a new Leuprolide acetate 22.5 mg depot formulation, when given as palliative treatment to prostate cancer patientsMedDRA version: 8.1Level: LLTClassification code 10007113Term: Cancer of prostateProstate cancerEUCTR2006-005964-24-GBItalfarmaco S.p.A.20
进行中(未招募)
不适用
Action of amlodipine oral solution in childreHypertensionEUCTR2013-005323-17-NLErasmus MC
已完成
不适用
Pharmacokinetic and pharmacodynamic properties of amlodipine oral liquid in the pediatric populatiohigh blood pressure10057166HypertensionNL-OMON41645Erasmus MC, Universitair Medisch Centrum Rotterdam20
